Prestige Consumer Healthcare
239 hedge funds and large institutions have $2.92B invested in Prestige Consumer Healthcare in 2017 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 110 increasing their positions, 70 reducing their positions, and 21 closing their positions.
444,200% more call options, than puts
Call options by funds: $8.89M | Put options by funds: $2K
57% more repeat investments, than reductions
Existing positions increased: 110 | Existing positions reduced: 70
48% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 21
8.1% more ownership
Funds ownership: 101.77% → 109.87% (+8.1%)
3% more funds holding
Funds holding: 232 → 239 (+7)
2% more capital invested
Capital invested by funds: $2.85B → $2.92B (+$68.9M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$83.5M |
| 2 |
MRCP
Manor Road Capital Partners
New York
|
+$45.7M |
| 3 |
JP Morgan Chase
New York
|
+$41.9M |
| 4 |
BlackRock
New York
|
+$25.6M |
| 5 |
Millennium Management
New York
|
+$13.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$22M |
| 2 |
Renaissance Technologies
New York
|
-$18.7M |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
-$15.8M |
| 4 |
TA
Teachers Advisors
New York
|
-$13.3M |
| 5 |
FA
Friess Associates
Greenville,
Delaware
|
-$10.1M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TI
251
Trexquant Investment
Stamford,
Connecticut
| – | -$280K | -5,300 | Closed |
|
|
MWNA
252
Marshall Wace North America
New York
| – | -$257K | -4,839 | Closed |
|
|
OI
253
Oakbrook Investments
Lisle,
Illinois
| – | -$206K | -3,900 | Closed |
|
|
MAM
254
Meeder Asset Management
Dublin,
Ohio
| – | -$77K | -1,448 | Closed |
|
255
Creative Planning
Overland Park,
Kansas
| – | -$59K | -1,108 | Closed |
|
|
PCM
256
Prelude Capital Management
New York
| – | -$53K | -1,000 | Closed |
|
|
AIM
257
Acrospire Investment Management
Chicago,
Illinois
| – | -$11K | -200 | Closed |
|
|
CTC
258
Central Trust Company
Jefferson City,
Missouri
| – | -$3K | -60 | Closed |
|
|
SMG
259
Spectrum Management Group
Indianapolis,
Indiana
| – | +$255 | +5 | New |
|
PBH Hedge Fund Activity: Q3 2017 in Review
239 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q3 2017, worth a combined $2.92B — up 2.4% from $2.85B a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new PBH positions and 21 closed out — a net gain of 10 holders — while 110 added to existing stakes and 70 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $83.5M. The largest seller was Lord, Abbett & Co, exiting entirely with an estimated $22M sold.
- 239 institutional investors held Prestige Consumer Healthcare (PBH) as of Q3 2017, up from 232 in Q2 2017.
- Funds reported $2.92B of Prestige Consumer Healthcare stock for Q3 2017, up 2.4% quarter-over-quarter.
- 31 funds opened new Prestige Consumer Healthcare positions in Q3 2017 and 21 closed out, a net change of +10 holders.
- The largest Prestige Consumer Healthcare buyer in Q3 2017 was Fidelity Investments, an estimated $83.5M added.
- The largest Prestige Consumer Healthcare seller in Q3 2017 was Lord, Abbett & Co, an estimated $22M sold.
Based on aggregated 13F filings for Q3 2017.